The globalisation of research in the pharmaceutical industry: A case of uneven development

The paper discusses different conceptualisations of the term globalisation of research. From this discussion five dimensions of globalisation of research are identified. Using three different type of data, the paper goes on to examine the extent, motivations and mechanism for the globalisation of research along these five dimensions among leading European and US pharmaceutical multinational companies (MNCs). The evidence for the period 1975-1998 shows that the general process of international expansion of research activities varied significantly between leading US and European MNCs. It is also clear that the development of the process of globalisation has proceeded unevenly along the five dimensions studied. The data also show the increasing concentration of both US and European research investment in the USA.